High-frequency uterine contractions at the time of non-cavitating embryo transfer influence adversely IVF-embryo transfer outcome. This prompted us to quantify prospectively the possible decline in uterine contraction frequency occurring during later stages of the luteal phase of ovarian stimulation, up to the time of blastocyst transfers, in 43 IVF-embryo transfer candidates. Contractility was assessed on the day of human chorionic gonadotrophin (HCG) administration, 4 days after HCG (non-cavitating embryo transfer; HCG ⍣ 4), and 7 days after HCG (blastocyst transfers; HCG ⍣ 7). For this, 2 min sagittal uterine scans were obtained by ultrasound and digitized with a computerized system for the assessment of uterine contraction frequency. Our results indicated that a slight, yet significant, decrease in uterine contraction frequency, observed from the day of HCG (4.4 ⍨ 0.2 contractions/ min) to HCG ⍣ 4 (3.5 ⍣ 0.2 contractions/min), was followed by a more pronounced, additional decrease between HCG ⍣ 4 and HCG ⍣ 7 (1.5 ⍨ 0.2 contractions/min; P < 0.001). In conclusion, during the luteal phase of ovarian stimulation, uterine contractility decreases progressively, and reaches a nearly quiescent status 7 days after HCG administration, at the time of blastocyst transfers. It is possible that such a uterine relaxation assists blastocyst implantation.
Introduction
between uterine contractility and embryo implantation in humans remained scarce because of the invasiveness of tradiGrowing evidence indicates that blastocysts have greater tional methods that required the introduction of pressure probes implantation potential compared with non-cavitating embryos into the uterine cavity (Henry et al., 1943; Hendricks, 1966; (Gardner et al., 1998a,b; Ménézo et al., 1998; Milki et al., Martinez-Gaudio et al., 1973 . Today, implantation rates of blastocysts often approxiHowever, the advent of high resolution ultrasound probes mate 50% (Gardner et al., 1998a,b; Schoolcraft et al., 1999) , permitted the direct visualization of myometrial activity in which allows a reduction in the number of transferred embryos ultrasound scans (Oike et al., 1990 ; Abramowicz and Archer, and, consequently, in the risk of high order multiple pregnan-1990; Lyons et al., 1991; IJland et al., 1997 IJland et al., , 1998 . Recently, cies. These data concur to make blastocyst transfers one of the reliability of the ultrasound approach for assessing uterine the most attractive improvements of modern IVF-embryo contractions was confirmed by demonstrating the concordance transfer. The explanations primarily proposed for the outstandof findings made simultaneously on ultrasound and intrauterine ing results obtained with this technique include the selection pressure recordings in an experimental model (Bulletti et al., of the healthiest embryos by an extended culture, and/or the 2000). improvement of endometrial receptivity on the fifth day after
In earlier investigations (Fanchin et al., 1998 (Fanchin et al., , 2000a , we fertilization.
have shown that a considerable fraction of IVF-embryo transfer Yet recent studies of uterine contractility in IVF-embryo patients have persistently high uterine contraction frequency transfer led us to consider an alternative, and possibly at the time of non-cavitating embryo transfer, 4 days after complementary, explanation for the high implantation rates human chorionic gonadotrophin (HCG) administration. Moreof blastocysts. It has been demonstrated that myometrial over, the observation of high-frequency uterine contractions contractile activity influences embryo implantation, possibly (Ͼ5.0 contractions/min) at the time of embryo transfer is through mechanical displacement of embryos, in both animals associated with markedly lower implantation and pregnancy (Pusey et al., 1980; Rogers et al., 1983) and humans (IJland rates per embryo transfer (4 and 14% respectively) as compared with cases with low-frequency contractions (ഛ3.0 contractions/ et al., 1997 Fanchin et al. 1998) . Data on the relation Uterine contractility and hormonal assessment min; 21 and 53% respectively) (Fanchin et al., 1998) . This may result from the mechanical expulsion of embryos from All women underwent three sequential ultrasonographic and hormonal evaluations that took place on the day of HCG administration, just the uterine cavity.
before the actual non-cavitating embryo transfer (4 days after HCG, In addition, more recent work on the hormonal regulation HCG ϩ 4), and on the day when blastocysts are commonly obtained of uterine contractility led us to speculate that utero-relaxation and transferred (HCG ϩ 7). Two minute ultrasound scans of a sagittal mediated by progesterone during the luteal phase takes a plane of the uterus were performed using a 7.5 MHz transvaginal longer time to be fully established in ovarian stimulation probe (Siemens Elegra ® ; Siemens SAS, Saint-Denis, France) at compared with the menstrual cycle (Fanchin et al., 2000a) .
approximately 1100 h by one single operator. Environmental condiThis may constitute a plausible explanation for the high uterine tions were standardized throughout ultrasound examinations. The contraction frequency seen at the time of non-cavitating embryo present study respected similar methodological characteristics as transfer in ovarian stimulation.
previously described (Fanchin et al., 1998 (Fanchin et al., , 2000a .
Based on this documentation, we decided to investigate the Briefly, images were digitized on-line using a two image/s rate with a computer-assisted image analysis system (IôTEC 3.1.2 ® ; possible advantages of delaying embryo transfer so that IôDP, Paris, France). As represented in Figure 1 , uterine contraction embryos reach the uterine cavity when contractility is frequency was assessed on time-mode graphs generated electronically attenuated and conditions for embryo implantation are using three-dimension reconstruction software (IôTEC 3.1.2 ® ; IôDP).
improved. For this, we compared uterine contraction characFor this, instead of swapping the ultrasound probe as for volume teristics on the day of HCG administration, the day of nonacquisition and three-dimension reconstruction, the probe was kept cavitating embryo transfer (HCG ϩ 4), and the day of steady and two-dimension images were acquired over time for 2 min.
blastocyst transfers (HCG ϩ 7).
Hence, in the electronic matrix, the z axis, instead of being the third dimension of volume, was represented by time. In the time-mode graphs, uterine contraction frequency was identified by the number
Materials and methods
vertical displacements of the myometrial-endometrial interface and Patient characteristics of the uterine cavity line over time. Precision of uterine contraction frequency measurements, expressed as interassay coefficient of We prospectively studied 43 consecutive ovarian stimulation cycles variation, was 8%. for IVF-embryo transfer undertaken in 43 infertile women. Only Direction of uterine contractions was assessed visually according women who were ഛ38 years of age, whose uteri were morphologically to a 20 image/s rate (10 times the normal speed) and classified normal as confirmed by hysteroscopy and ultrasound scans, and who arbitrarily into four types: cervix-to-fundus or retrograde, fundus-tohad at least two good quality non-cavitating embryos (defined as cervix or antegrade, antagonistic (contractions starting simultaneuniform sized and shaped blastomeres, ooplasm having no granularity ously on the cervix and on the fundus and meeting on the middle of the and a maximum fragmentation of 10%) available for embryo transfer uterus) and non-propagated contractions (local myometrial activity). were included. Clinical indications for IVF-embryo transfer were Serum FSH was measured by an immunometric technique using sperm abnormalities (63%), tubal abnormalities (21%), unexplained an Amerlite ® kit (Ortho Clinical Diagnostics, Strasbourg, France). infertility (14%), and endometriosis (2%). An informed consent was Intra-assay and interassay CV were, respectively, 5 and 7% and obtained from all patients and this investigation received the approval sensitivity was 0.1 mIU/ml for FSH. Serum progesterone was of our internal institutional review board. measured by radioimmunoassay using a I 125 Progesterone Coatria ® Ovarian stimulation protocol kit (Bio-Mérieux, Paris, France). Sensitivity was 0.05 ng/ml and intra-assay and interassay CV were, respectively, 8 and 11% for A single injection of a time-release gonadotrophin releasing-hormone progesterone. Serum oestradiol was determined by an immuno-(GnRH) agonist, triptorelin, (3.0 mg i.m., Decapeptyl ® ; Ibsen-Biotech metric technique using an Estradiol-60 Amerlite ® kit (Ortho Clinical Laboratories, Paris, France) was administered on cycle day 2. Eighteen Diagnostics). Sensitivity was 14 pg/ml, and intra-assay and interassay days later, complete pituitary desensitization was confirmed by CV were 8 and 9% for oestradiol respectively. documenting low plasma oestradiol Ͻ40 pg/ml and luteinizing hormone (LH) ഛ2 mIU/ml concentrations. Patients also had a Statistics conventional ultrasound examination to exclude ovarian cysts and verify that endometrial thickness was Ͻ5 mm. Recombinant FSH Measures of central tendency used were means and measures of variability were standard errors. When data distribution was nontherapy (Puregon ® ; Organon Pharmaceuticals, Saint-Denis, France) was then initiated at a dosage of 225 IU/day for the first 5 days parametric, medians and ranges were used. Changes in uterine contraction frequency and ovarian hormone levels were assessed of ovarian stimulation. Further FSH doses and timing of HCG (Gonadotrophine Chorionique Endo ® ; Organon Pharmaceuticals, using the paired Student's t-test and repeated-measures analysis of variance (ANOVA) when appropriate. Hormonal influence on uterine 10 000 IU, i.m.) administration were adjusted according to the usual criteria of follicular maturation determined by ultrasound and contractility was assessed using simple regression. A P value of Ͻ 0.05 was considered statistically significant. oestradiol findings. Administration of HCG was performed when at least three follicles exceeded 17 mm in diameter and oestradiol concentrations per mature follicle (ജ17 mm in diameter) were Ͼ300 Results pg/ml. Oocytes were retrieved 36 h after HCG administration by transvaginal ultrasound-guided aspiration.
Patients, ovarian stimulation and embryology data
All embryo transfers were performed 2 days after oocyte retrieval Median age of patients was 33.0 years (range: 26-38), and using Frydman catheters (CCD Laboratories, Paris, France). Luteal mean cycle day 3 serum FSH and oestradiol concentrations, phase was supported with progesterone (Crinone ® 8%; Ares-Serono measured in a prior cycle, were within the normal range at SA, Geneva, Switzerland) administered daily by vaginal route starting on the evening of embryo transfer.
5.1 Ϯ 0.2 mIU/ml and 27 Ϯ 2 pg/ml respectively. Ovarian 32, 9, and 2% respectively on the day of HCG administration. This frequency distribution remained comparable on HCG ϩ 4 (56, 25, 14, and 5% respectively). On HCG ϩ 7, however, prevalence of uterine contraction changed as compared with HCG administration (31, 23, 23, and 25% respectively), with a reduction of retrograde uterine contraction (P Ͻ 0.01) and a more pronounced increase in non-propagated UC (P Ͻ 0.001).
As expected, mean serum progesterone concentrations increased after HCG administration from 0.72 Ϯ 0.07 ng/ml to 85.2 Ϯ 6.9 ng/ml on HCG ϩ 4 (P Ͻ 0.001). A further increase in progesterone concentrations occurred from HCG ϩ 4 to HCG ϩ 7 (134.5 Ϯ 11.1 ng/ml, P Ͻ 0.001). Serum oestradiol concentrations fell after HCG administration from 2497 Ϯ 134 pg/ml to 1058 Ϯ 61 pg/ml on HCG ϩ 4 from the day of HCG administration to HCG ϩ 7 (expected day of blastocyst transfers) (P Ͻ 0.001, repeated-measures analysis of (P Ͻ 0.001), before increasing on HCG ϩ 7 (1952 Ϯ 81 pg/ variance). ml, P Ͻ 0.001).
On the day of HCG administration, serum progesterone stimulation lasted 11.3 Ϯ 0.2 days and required 32.4 Ϯ 1.7 concentrations failed to correlate with uterine contraction 75 IU FSH ampoules. On the day of HCG administration, frequency. On HCG ϩ 4, as expected, we observed a negative serum progesterone and oestradiol concentrations reached and significant correlation between serum progesterone concen-0.81 Ϯ 0.12 ng/ml and 2496 Ϯ 134 pg/ml respectively. Mean trations and UC frequency (r ϭ -0.43; P Ͻ 0.004). Similarly, numbers of mature oocytes retrieved and available embryos on HCG ϩ 7, serum progesterone concentrations and UC were 10.6 Ϯ 0.6 and 5.6 Ϯ 0.4 respectively. Median number frequency correlated negatively (r ϭ -0.34; P Ͻ 0.03). Serum of embryos transferred was three (range: 2-4).
oestradiol concentrations did not correlate with UC frequency at any time. No statistically significant correlation was identiUterine contractility fied between direction of uterine contraction and serum Changes in uterine contraction (UC) frequency from the day progesterone or oestradiol concentrations. of HCG administration to HCG ϩ 7 are depicted in Figure 2 . Mean UC frequency, which reached 4.4 Ϯ 0.2 UC/min (range: Discussion 1.5-8.5) on the day of HCG administration, decreased slightly yet significantly on HCG ϩ 4 at 3.5 Ϯ 0.2 UC/min (range:
The present study was conducted to investigate the changes in uterine contractility that occur during the first 7 days 1.0-7.5)(P Ͻ 0.003). On HCG ϩ 7, an additional and noticeable reduction of UC frequency was observed (1.5 Ϯ 0.2 UC/min, following HCG administration, i.e. up to the time when blastocysts are commonly transferred into the uterus. It was range: 0.0-3.5, P Ͻ 0.001). The prevalence of each uterine contraction type (cervix-to-fundus or retrograde, fundus-toprompted by the reported relationship between uterine contractions and embryo implantation (Ijland et al., 1997 (Ijland et al., , 1998 , and cervix or antegrade, antagonistic, and non-propagated) was 57, by our previous findings that pregnancy and implantation rates Further, the present study showed an increasing prevalence are decreased when contractile frequency is exacerbated on of non-propagated uterine contractions from the day of HCG the day of non-cavitating embryo transfer (Fanchin et al., administration to HCG ϩ 7. Whether or not this phenomenon 1998). The present results indicate a remarkable fall in uterine may be attributed to an action of progesterone as well as contraction frequency on HCG ϩ 7. This may account, at its possible role on embryo implantation deserves further least in part, for the putative increase in implantation potential elucidation. Finally, it is important to mention that the of blastocysts. Furthermore, we observed a significant recontractile activity of the uterus is a complex phenomenon organization of uterine contraction direction. that involves either superficial or profound muscle layers with Because the number of blastocyst transfers is limited at our generalized and local consequences. Hence, the complete institution, it was impractical to enrol enough cases to assess assessment of all uterine contractility characteristics by ultrauterine contraction characteristics on the day of actual blastosound may sometimes be difficult. This methodological limitacyst transfers. In an effort to overcome this limitation, we tion led us to consider only contraction frequency and, to a studied a selected population (women aged ഛ38 years, dislesser extent, direction of propagation in our present and past playing adequate ovarian follicular reserve and with at least ultrasound studies (Fanchin et al., 1998 (Fanchin et al., , 2000a . Indeed, recent two good quality embryos available for embryo transfer on data indicated that, during the luteal phase, the uterine fundus HCG ϩ 4) who had good probability of reaching the blastocyst shows only relative quiescence and the residual contractile transfer. Therefore, these methodological characteristics may may be important to blastocyst positioning (Kunz et al., 2000) . authorize the extrapolation of present uterine contraction data
In conclusion, concurring with the putative embryo selection observed on HCG ϩ 7 (theoretical day of blastocyst transfers) through extended culture, the nearly quiescent status of the to real blastocyst transfers conditions. However, it is noteuterus reached on the day of blastocyst transfers may avoid worthy that possible direct and local influence of embryos embryo displacement in the endometrial cavity and, therefore, present in the uterine cavity on HCG ϩ 4 and uterine assist implantation. Hence, the present data may offer an contractility on HCG ϩ 7 could not be ruled out by the present additional explanation of the high implantation rates reported study and need further investigation.
after blastocyst transfers (Gardner et al., 1998a,b ; Ménézo The observed reduction of uterine contraction frequency et al., 1998; Schoolcraft et al., 1999; Huisman et al., 2000) . after HCG administration presumably results from the uteroFurther, based on these results, extending culture and relaxing properties of progesterone, both secreted by multiple transferring blastocysts instead on 2-to 8-cell embryos may corpora lutea and administered exogenously after embryo be opportune in cases of high uterine contraction frequency transfer. In support of this, the present data indicate that serum (ജ5 contractions/min) (Fanchin et al., 1998) on the day of progesterone concentrations correlate negatively with uterine non-cavitating embryo transfers. contraction frequency not only on HCG ϩ 4, thus confirming our earlier reports (Fanchin et al., 1998 (Fanchin et al., , 2000a , but also on HCG ϩ 7. Conversely, the myo-relaxing action of progesterone References may depend on both its absolute circulating levels and the Abramowicz, J.S. and Archer, D.F. (1990) Uterine endometrial peristalsis-a duration of uterine exposure to progesterone. In agreement transvaginal ultrasound study. Fertil. Steril., 54, [451] [452] [453] [454] with this hypothesis, uterine contraction frequency decreases Bulletti, C., de Ziegler, D., Polli, V. et al. (2000) Uterine contractility during progressively during the luteal phase of the menstrual cycle the menstrual cycle. Hum. Reprod., 15 (Suppl. 1), 81-89. Croxatto, H.B., Ortiz, M.E., Diaz, S. et al. (1978) Studies on the duration of (Abramowicz and Archer, 1990; Lyons et al., 1991) . The luteal egg transport by the human oviduct. II. Ovum location at various intervals reduction of uterine contractile activity potentially assists following luteinizing hormone peak. Am J. Obstet. Gynecol., 132, [629] [630] [631] [632] [633] [634] the embryo implantation process. Accordingly, in natural gonadotropin administration fails to increase plasma androgens in controlled Hence, it is conceivable that 2-to 8-cell embryo transfers ovarian hyperstimulation. Fertil. Steril., 73, [275] [276] [277] [278] [279] are often performed too early when utero-relaxation mediated Fanchin, R., Righini, C., Olivennes, F. et al. (1998) Uterine contractions at the time of embryo transfer alter pregnancy rates in in-vitro fertilization.
by progesterone has not been fully exerted. Indeed, despite Hum. Reprod., 13, 1968 -1974 serum progesterone reaching very high mean concentrations
